TCT-531 EXCITE ISR: A Prospective, Randomized Controlled Trial of Excimer Laser Atherectomy vs Balloon Angioplasty for the Treatment of Femoropopliteal In-Stent Restenosis

Eric J. Dippel,Prakash Makam,Richard Kovach,Jon C. George,Raghotham R. Patlola,D. Christopher Metzger,Carlos Mena,Peter Soukas,Pedro Colon-Hernadez,Matthew Stark,Craig M. Walker

TCT-531 EXCITE ISR: A Prospective, Randomized Controlled Trial of Excimer Laser Atherectomy vs Balloon Angioplasty for the Treatment of Femoropopliteal In-Stent Restenosis

2014

Eric J. Dippel
Prakash Makam
Richard Kovach
Jon C. George
Raghotham R. Patlola
D. Christopher Metzger
Carlos Mena
Peter Soukas
Pedro Colon-Hernadez
Matthew Stark
Craig M. Walker

Femoropopliteal stenting for treatment of peripheral arterial disease has shown superiority to balloon angioplasty (PTA) for the treatment of lifestyle limiting claudication and critical limb ischemia. However, in-stent restenosis (ISR) after femoropopliteal artery stenting remains a challenging

Keywords:

Excimer laser
Randomized controlled trial
Restenosis
Angioplasty
Atherectomy
Stent
Medicine
Internal medicine
Cardiology
Artery
Balloon
Claudication
Critical limb ischemia

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations